Originally published byEU-Startups
TidalSense (formerly Cambridge Respiratory Innovations), a Cambridge-based AI-powered respiratory diagnostic, today announced a €16.6 million ($19 million) funding round to accelerate commercialisation in the UK and support globalisation of the technology, including to the USA. The round included investment from new investor Cross-Border Impact Ventures, and returning investors BGF, Airstream Capital, and Foresight Group. This […]
The post Cambridge’s TidalSense raises €16.6 million to turn the tide on respiratory diagnostics with patented AI tech appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Cloud giants pour nearly $600B into capex as AI demand surges
14h ago
As Larry Ellison bets the farm, Oracle says it loves AI-written code, just not in OpenJDK
1d ago
UK government investment arm cops to 40-hour leak of officials' contact details
1d ago
IT boss left root session open for bring-your-kid-to-work day
1d ago
Sci-fi authors Scalzi and Stross decry AI's dystopian impact on their craft
1d ago